Hepatitis C virus non-structural protein 3 (HCV NS3): A multifunctional antiviral target

Kevin D. Raney, Suresh D. Sharma, Ibrahim M. Moustafa, Craig E. Cameron

Research output: Contribution to journalShort survey

115 Citations (Scopus)

Abstract

Hepatitis C virus non-structural protein 3 contains a serine protease and an RNA helicase. Protease cleaves the genomeencoded polyprotein and inactivates cellular proteins required for innate immunity. Protease has emerged as an important target for the development of antiviral therapeutics, but drug resistance has turned out to be an obstacle in the clinic. Helicase is required for both genome replication and virus assembly. Mechanistic and structural studies of helicase have hurled this enzyme into a prominent position in the field of helicase enzymology. Nevertheless, studies of helicase as an antiviral target remain in their infancy.

Original languageEnglish (US)
Pages (from-to)22725-22731
Number of pages7
JournalJournal of Biological Chemistry
Volume285
Issue number30
DOIs
StatePublished - Jul 23 2010

Fingerprint

Viral Structural Proteins
Viruses
Hepacivirus
Antiviral Agents
Peptide Hydrolases
Viral Drug Resistance
RNA Helicases
Virus Assembly
Polyproteins
Serine Proteases
Innate Immunity
Proteins
Genes
Genome
Enzymes
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Raney, Kevin D. ; Sharma, Suresh D. ; Moustafa, Ibrahim M. ; Cameron, Craig E. / Hepatitis C virus non-structural protein 3 (HCV NS3) : A multifunctional antiviral target. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 30. pp. 22725-22731.
@article{f6ce1adc159e4882902ec9f64fe9cd5b,
title = "Hepatitis C virus non-structural protein 3 (HCV NS3): A multifunctional antiviral target",
abstract = "Hepatitis C virus non-structural protein 3 contains a serine protease and an RNA helicase. Protease cleaves the genomeencoded polyprotein and inactivates cellular proteins required for innate immunity. Protease has emerged as an important target for the development of antiviral therapeutics, but drug resistance has turned out to be an obstacle in the clinic. Helicase is required for both genome replication and virus assembly. Mechanistic and structural studies of helicase have hurled this enzyme into a prominent position in the field of helicase enzymology. Nevertheless, studies of helicase as an antiviral target remain in their infancy.",
author = "Raney, {Kevin D.} and Sharma, {Suresh D.} and Moustafa, {Ibrahim M.} and Cameron, {Craig E.}",
year = "2010",
month = "7",
day = "23",
doi = "10.1074/jbc.R110.125294",
language = "English (US)",
volume = "285",
pages = "22725--22731",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "30",

}

Hepatitis C virus non-structural protein 3 (HCV NS3) : A multifunctional antiviral target. / Raney, Kevin D.; Sharma, Suresh D.; Moustafa, Ibrahim M.; Cameron, Craig E.

In: Journal of Biological Chemistry, Vol. 285, No. 30, 23.07.2010, p. 22725-22731.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Hepatitis C virus non-structural protein 3 (HCV NS3)

T2 - A multifunctional antiviral target

AU - Raney, Kevin D.

AU - Sharma, Suresh D.

AU - Moustafa, Ibrahim M.

AU - Cameron, Craig E.

PY - 2010/7/23

Y1 - 2010/7/23

N2 - Hepatitis C virus non-structural protein 3 contains a serine protease and an RNA helicase. Protease cleaves the genomeencoded polyprotein and inactivates cellular proteins required for innate immunity. Protease has emerged as an important target for the development of antiviral therapeutics, but drug resistance has turned out to be an obstacle in the clinic. Helicase is required for both genome replication and virus assembly. Mechanistic and structural studies of helicase have hurled this enzyme into a prominent position in the field of helicase enzymology. Nevertheless, studies of helicase as an antiviral target remain in their infancy.

AB - Hepatitis C virus non-structural protein 3 contains a serine protease and an RNA helicase. Protease cleaves the genomeencoded polyprotein and inactivates cellular proteins required for innate immunity. Protease has emerged as an important target for the development of antiviral therapeutics, but drug resistance has turned out to be an obstacle in the clinic. Helicase is required for both genome replication and virus assembly. Mechanistic and structural studies of helicase have hurled this enzyme into a prominent position in the field of helicase enzymology. Nevertheless, studies of helicase as an antiviral target remain in their infancy.

UR - http://www.scopus.com/inward/record.url?scp=77954931489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954931489&partnerID=8YFLogxK

U2 - 10.1074/jbc.R110.125294

DO - 10.1074/jbc.R110.125294

M3 - Short survey

C2 - 20457607

AN - SCOPUS:77954931489

VL - 285

SP - 22725

EP - 22731

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 30

ER -